Voxelotor
Common brands: Oxbryta, Hydrea, Siklos, Droxia, Hydroxyurea
Top reporter: Global Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc.
Hemoglobin S Polymerization Inhibitor [EPC]Antimetabolite [EPC]Vitamin C [EPC]Vitamin B12 [EPC]Vitamin D [EPC]
22,291
Total Reports
17,111
Serious Reports
414
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (1.86%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Voxelotor.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | SICKLE CELL ANAEMIA WITH CRISIS | 11,216 | |
| 2 | PRODUCT DOSE OMISSION ISSUE | 5,172 | |
| 3 | DIARRHOEA | 3,187 | |
| 4 | OFF LABEL USE | 2,416 | |
| 5 | NAUSEA | 2,016 | |
| 6 | HEADACHE | 1,691 | |
| 7 | ABDOMINAL PAIN UPPER | 1,171 | |
| 8 | PAIN | 1,082 | |
| 9 | THERAPY CESSATION | 1,040 | |
| 10 | FATIGUE | 1,007 | |
| 11 | ABDOMINAL DISCOMFORT | 969 | |
| 12 | THERAPY INTERRUPTED | 900 | |
| 13 | VOMITING | 833 | |
| 14 | HAEMOGLOBIN DECREASED | 752 | |
| 15 | ABDOMINAL PAIN | 627 | |
| 16 | RASH | 574 | |
| 17 | MALAISE | 535 | |
| 18 | PNEUMONIA | 431 | |
| 19 | ACUTE CHEST SYNDROME | 391 | |
| 20 | PYREXIA | 367 | |
| 21 | DIZZINESS | 362 | |
| 22 | DEATH | 331 | |
| 23 | HOSPITALISATION | 307 | |
| 24 | PRODUCT USE COMPLAINT | 298 | |
| 25 | THERAPY NON-RESPONDER | 295 | |
| 26 | INTENTIONAL PRODUCT MISUSE | 277 | |
| 27 | COVID-19 | 271 | |
| 28 | PAIN IN EXTREMITY | 264 | |
| 29 | PRURITUS | 264 | |
| 30 | WEIGHT DECREASED | 251 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.